Rchr
J-GLOBAL ID：201901016402260008
Update date: Sep. 01, 2024
Yamada Koshi
ヤマダ コウシ | Yamada Koshi
Affiliation and department：
Research field (1)：
Nephrology
Research theme for competitive and other funds (1)：
- 2022 - 2025 IgA腎症の進展機序におけるB細胞受容体シグナル伝達と異常IgA1産生制御の検証
Papers (11)：
-
Masayuki Maiguma, Masao Kihara, Maki Hamaguchi, Takashi Kobayashi, Koshi Yamada, Miyuki Takagi, Harumi Saeki, Tomohito Gohda, Yusuke Suzuki. Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice. CEN case reports. 2024
-
Koshi Yamada, Zhi-Qiang Huang, Colin Reily, Todd J Green, Hitoshi Suzuki, Jan Novak, Yusuke Suzuki. LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy. Kidney international reports. 2024. 9. 2. 423-435
-
Koshi Yamada, Jan Novak, Yusuke Suzuki. GWAS-follow-up Studies Identified a Connection between Abnormal LIF/JAK2/STAT1 Signaling and Overproduction of Galactose-Deficient IgA1 in the Tonsillar IgA1-Secreting Cells from Patients with IgA Nephropathy. Journal of clinical research & bioethics. 2024. 15. 1
-
Mingfeng Lee, Hitoshi Suzuki, Kei Ogiwara, Ryosuke Aoki, Rina Kato, Maiko Nakayama, Yusuke Fukao, Yoshihito Nihei, Toshiki Kano, Yuko Makita, et al. The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy. Kidney International. 2023. 104. 5. 943-955
-
Toshiki Kano, Hitoshi Suzuki, Yuko Makita, Yoshihito Nihei, Yusuke Fukao, Maiko Nakayama, Mingfeng Lee, Rina Kato, Ryosuke Aoki, Koshi Yamada, et al. Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy. Biomedicines. 2022. 10. 12. 3027-3027
ｍore...
MISC (29)：
-
Koshi Yamada, Kei Ogiwara, Colin Reily, Bruce A Julian, Todd J Green, Hitoshi Suzuki, Yusuke Suzuki, Jan Novak. #1261 A small-molecule inhibitor of Bruton's tyrosine kinase reduces production of galactose-deficient IgA1 in IgA nephropathy. Nephrology Dialysis Transplantation. 2024. 39. Supplement_1
-
山田 耕嗣. 腎臓専門医講座 腎臓専門医のための模擬テスト(43)解答と解説-Course for Nephrologist : Prep test for nephrologist(43)answer and explanation. 腎臓内科 = Nephrology / 腎臓内科編集委員会 編. 2023. 18. 2. 262-264
-
Mori K, Yamada K, Aoki R, Saeki H, Kobayashi T, Maiguma M, Kihara M, Ueda S, Gohda T, Suzuki Y. A case of IgA vasculitis that developed gross hematuria and lower -limb purpura following covid-19 vaccines. Kidney International Report. 2023. 8. S450
-
廣瀬樹, 田中翔大, 木原正夫, 小林敬, 山田耕嗣, 上田誠二, 合田朋仁, 鈴木祐介. 白質脳症で発症し持続的血液透析濾過(CHDF)が奏功した尿毒症性脳症の一例. 日本腎臓学会誌(Web). 2023. 65. 6-E
-
山田耕嗣, 鈴木祐介. 血栓・止血の異常を理解する-広くて深い基礎知識[Chapter2]血栓・止血に関連する疾患 C.出血性疾患 IgA血管炎. 内科. 2023. 132. 4
ｍore...
Books (10)：
-
Naika
2023
-
Diseases of the Kidney 3rd edition
2022
-
CKD診療テキスト(改訂2版)
中外医学社 2022
-
尿所見のみかた、考え方
中外医学社 2018
-
腎臓病・高血圧と薬剤
中外医学社 2009
ｍore...
Lectures and oral presentations (30)：
-
A small-molecule inhibitor of Bruton's tyrosine kinase reduces production of galactose-deficient IgA1 in IgA nephropathy
(61th ERA congress (Stockholm) 2024)
-
白質脳症で発症し持続的血液透析濾過(CHDF)が奏功した尿毒症性脳症の一例
(第53回 日本腎臓学会東部学術集会 (仙台) 2023)
-
LIF/JAK2/STAT1 signaling enhances production of galactose-deficient IgA1 by IgA1-producing cell lines derived from tonsils of patients with IgA nephropathy
(2022)
-
A case of IgA vasculitis with skin and kidney tissues positive for anti-galactose-deficient IgA1 that developed gross hematuria following COVID-19 vaccination
(2022)
-
A case of IgA vasculitis with purpura following COVID vaccinations successful steroid pulse therapy
(2022)
ｍore...
Professional career (1)：
Awards (1)：
- 2020 - 国際学術誌「Kidney Diseases」 Best Research Paper Award 2019
Association Membership(s) (4)：
日本糖尿病学会
, 日本透析医学会
, 日本腎臓学会
, 日本内科学会
